Amedisys/ US0234361089 /
| 15/05/2024 21:59:43 | Chg. -0.26 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 95.45USD | -0.27% | 10,052 Turnover: 960,858.66 |
-Bid Size: - | -Ask Size: - | 3.12 bill.USD | - | - |
Assets
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 31.1000 | 29.4490 | 28.1000 | 23.7000 | 18.4000 | ||||||
| Intangible Assets | 46.0610 | 44.1320 | 64.7000 | 74.2000 | 111.2000 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 502.3260 | 493 | 912.1910 | 1,205.2140 | 1,500.2840 | ||||||
| Inventories | - | - | - | - | - | ||||||
| Accounts Receivable | 201.1960 | 188.9720 | 237.5960 | 255.1450 | 274.9610 | ||||||
| Cash and Cash Equivalents | 86.3630 | 20.2290 | 30.3000 | 81.8000 | 42.7000 | ||||||
| Current Assets | 311.1560 | 224.1180 | 350.5540 | 361.9840 | 356.6840 | ||||||
| Total Assets | 813.4820 | 717.1180 | 1,262.7450 | 1,567.1980 | 1,856.9680 | ||||||
Liabilities
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 25.3840 | 28.5310 | 31.2590 | 42.6740 | 38.2170 | ||||||
| Long-term debt | 78.2000 | 5.7750 | 232.3000 | 204.5000 | 432.0750 | ||||||
| Liabilities to Banks | 88.8000 | 5.8000 | 232.3000 | - | - | ||||||
| Provisions | - | 1.6000 | 37.7000 | - | - | ||||||
| Liabilities | 297.0560 | 234.4850 | 621.2320 | 756.4570 | 880.6450 | ||||||
| Share Capital | .0350 | .0360 | .0370 | .0380 | .0380 | ||||||
| Total Equity | 516.4260 | 482.6330 | 641.5130 | 810.7410 | 976.3230 | ||||||
| Minority Interests | 1.1050 | 1.0510 | 1.0630 | 1.5170 | 44.9720 | ||||||
| Total liabilities equity | 813.4820 | 717.1180 | 1,262.7450 | 1,567.1980 | 1,856.9680 | ||||||
Income Statement
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 1,533.7000 | 1,662.5780 | 1,955.6000 | 2,071.5000 | 2,214.1000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 78.5240 | 155.1000 | 177.5000 | 219.3000 | 251.9000 | ||||||
| Interest Income | -4.8730 | -7.0920 | -14.4370 | -10.7460 | -9.4760 | ||||||
| Income Before Taxes | 80.8010 | 158.9880 | 170.4100 | 210.8190 | 280.2310 | ||||||
| Income Taxes | -50.1000 | -38.8590 | -42.5000 | -25.6000 | -70.1000 | ||||||
| Minority Interests Profit | -.3820 | -.7830 | -1.0740 | -1.5760 | -1.0940 | ||||||
| Net Income | 30.3000 | 119.3460 | 126.8000 | 183.6000 | 209.0720 | ||||||
Per Share
Cash Flow
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 105.7310 | 223.4830 | 202 | 288.9520 | 188.8930 | ||||||
| Cash Flow from Investing Activities | -44.0270 | -22.1930 | -352.9480 | -287.1080 | -281.6070 | ||||||
| Cash Flow from Financing | -5.5380 | -267.4240 | 227.2090 | -14.9770 | 55.1260 | ||||||
| Decrease / Increase in Cash | 56.1660 | -66.1340 | 76.2610 | -13.1330 | -37.5880 | ||||||
| Employees | 17,900 | 21,000 | 21,300 | - | - | ||||||
